bivalirudin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Bivalirudin.
Product ID | 25021-405_8d2a843f-68c9-48f4-ac50-7de7ab476dbf |
NDC | 25021-405 |
Product Type | Human Prescription Drug |
Proprietary Name | bivalirudin |
Generic Name | Bivalirudin |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2019-01-15 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA091602 |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | BIVALIRUDIN |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-01-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA091602 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-01-15 |
Marketing End Date | 2019-01-15 |
Ingredient | Strength |
---|---|
BIVALIRUDIN | 250 mg/1 |
SPL SET ID: | eb465d12-f1ec-4b84-bb42-a0abb09d2085 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0409-8300 | Bivalirudin | BIVALIRUDIN |
0781-3158 | bivalirudin | bivalirudin |
0781-9158 | bivalirudin | bivalirudin |
16729-275 | Bivalirudin | Bivalirudin |
25021-405 | bivalirudin | bivalirudin |
52958-034 | Bivalirudin | Bivalirudin |
55111-652 | Bivalirudin | Bivalirudin |
55150-210 | BIVALIRUDIN | BIVALIRUDIN |
60505-6101 | Bivalirudin | bivalirudin |
63323-562 | Bivalirudin | Bivalirudin |
67457-256 | Bivalirudin | bivalirudin |
69097-601 | bivalirudin | bivalirudin |
70511-141 | bivalirudin | bivalirudin |
70860-402 | Bivalirudin | Bivalirudin |
72572-035 | bivalirudin | bivalirudin |
71288-427 | BIVALIRUDIN | BIVALIRUDIN |
0781-3447 | Angiomax | bivalirudin |
65293-001 | Angiomax | bivalirudin |